Context Therapeutics Inc. - Common Stock (CNTX)
CUSIP: 21077P108
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 91,741,639
- Total 13F shares
- 56,682,696
- Share change
- -401,956
- Total reported value
- $111,154,599
- Price per share
- $1.96
- Number of holders
- 42
- Value change
- -$854,175
- Number of buys
- 19
- Number of sells
- 16
Quarterly Holders Quick Answers
What is CUSIP 21077P108?
CUSIP 21077P108 identifies CNTX - Context Therapeutics Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 21077P108:
Top shareholders of CNTX - Context Therapeutics Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Avidity Partners Management LP |
13F
|
Company |
8.1%
|
7,419,355
|
$14,875,807 | — | 30 Jun 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
8.1%
|
7,419,355
|
$14,875,807 | — | 30 Jun 2024 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
8.1%
|
7,419,355
|
$14,875,807 | — | 30 Jun 2024 | |
| Nextech Invest Ltd. |
13F
|
Company |
8.1%
|
7,419,355
|
$14,875,807 | — | 30 Jun 2024 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
5.6%
|
5,161,290
|
$10,348,386 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.9%
|
4,502,198
|
$9,026,907 | — | 30 Jun 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.5%
|
2,258,065
|
$4,527,420 | — | 30 Jun 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
2.1%
|
1,935,484
|
$3,880,645 | — | 30 Jun 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
2.1%
|
1,935,484
|
$3,851,613 | — | 30 Jun 2024 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
2.1%
|
1,886,232
|
$3,781,895 | — | 30 Jun 2024 | |
| Blackstone Inc. |
13F
|
Company |
2%
|
1,838,709
|
$3,686,612 | — | 30 Jun 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
1.8%
|
1,619,140
|
$3,246,376 | — | 30 Jun 2024 | |
| Sio Capital Management, LLC |
13F
|
Company |
1.4%
|
1,328,352
|
$2,663,346 | — | 30 Jun 2024 | |
| Velan Capital Investment Management LP |
13F
|
Company |
1.4%
|
1,290,323
|
$2,587,098 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.93%
|
851,696
|
$1,707,650 | — | 30 Jun 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.7%
|
645,161
|
$1,293,548 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.67%
|
618,174
|
$1,239,542 | — | 30 Jun 2024 | |
| Altium Capital Management LLC |
13F
|
Company |
0.39%
|
360,001
|
$721,802 | — | 30 Jun 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.32%
|
293,758
|
$588,985 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.19%
|
174,497
|
$349,866 | — | 30 Jun 2024 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.14%
|
125,852
|
$252,000 | — | 30 Jun 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.12%
|
108,376
|
$217,294 | — | 30 Jun 2024 | |
| Mill Creek Capital Advisors, LLC |
13F
|
Company |
0.11%
|
104,631
|
$209,785 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.1%
|
92,107
|
$184,675 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.07%
|
65,200
|
$130,726 | — | 30 Jun 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
41,469
|
$83,145 | — | 30 Jun 2024 | |
| Clear Harbor Asset Management, LLC |
13F
|
Company |
0.04%
|
36,000
|
$72,180 | — | 30 Jun 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.03%
|
24,750
|
$50,000 | — | 30 Jun 2024 | |
| CAXTON CORP |
13F
|
Company |
0.02%
|
18,403
|
$36,899 | — | 30 Jun 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
0.02%
|
16,294
|
$32,669 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.02%
|
13,844
|
$27,757 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
10,776
|
$21,606 | — | 30 Jun 2024 | |
| Tarek Sahmoud |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
35,000
mixed-class rows
|
$8,415 | — | 16 Aug 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
500
|
$1,003 | — | 30 Jun 2024 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
400
|
$802 | — | 30 Jun 2024 | |
| Richard J. Berman |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 13 Jun 2024 | |
| Evan G. Dick |
3/4/5
|
Former Section 16 officer |
—
class O/S missing
|
29,223
|
— | — | 15 Feb 2022 | |
| William F. Rencher |
3/4/5
|
Former Section 16 officer |
—
class O/S missing
|
8,000
|
— | — | 15 Feb 2022 |
Institutional Holders of Context Therapeutics Inc. - Common Stock (CNTX) as of Q3 2024
As of 30 Sep 2024,
Context Therapeutics Inc. - Common Stock (CNTX) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,682,696 shares.
The largest 10 holders included
Deep Track Capital, LP, Nextech Invest Ltd., Avidity Partners Management LP, GREAT POINT PARTNERS LLC, Blue Owl Capital Holdings LP, VANGUARD GROUP INC, Blackstone Inc., Nantahala Capital Management, LLC, FRANKLIN RESOURCES INC, and Ally Bridge Group (NY) LLC.
This page lists
42
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
34
Q3 2024 holders
42
Holder diff
8
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.